# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001558370-25-008984
Filing Date
2025-06-30
Accepted
2025-06-30 06:59:26
Documents
44
Period of Report
2025-06-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | acrs-20250630x8k.htm iXBRL | 8-K | 39449
2 | EX-99.1 | acrs-20250630xex99d1.htm | EX-99.1 | 47756
3 | GRAPHIC | acrs-20250630xex99d1g001.jpg | GRAPHIC | 134865
4 | GRAPHIC | acrs-20250630xex99d1g002.jpg | GRAPHIC | 347017
5 | GRAPHIC | acrs-20250630xex99d1g003.jpg | GRAPHIC | 215746
6 | GRAPHIC | acrs-20250630xex99d1g004.jpg | GRAPHIC | 121254
7 | GRAPHIC | acrs-20250630xex99d1g005.jpg | GRAPHIC | 118961
8 | GRAPHIC | acrs-20250630xex99d1g006.jpg | GRAPHIC | 92859
9 | GRAPHIC | acrs-20250630xex99d1g007.jpg | GRAPHIC | 163165
10 | GRAPHIC | acrs-20250630xex99d1g008.jpg | GRAPHIC | 127470
11 | GRAPHIC | acrs-20250630xex99d1g009.jpg | GRAPHIC | 140796
12 | GRAPHIC | acrs-20250630xex99d1g010.jpg | GRAPHIC | 130440
13 | GRAPHIC | acrs-20250630xex99d1g011.jpg | GRAPHIC | 126265
14 | GRAPHIC | acrs-20250630xex99d1g012.jpg | GRAPHIC | 143953
15 | GRAPHIC | acrs-20250630xex99d1g013.jpg | GRAPHIC | 113733
16 | GRAPHIC | acrs-20250630xex99d1g014.jpg | GRAPHIC | 123103
17 | GRAPHIC | acrs-20250630xex99d1g015.jpg | GRAPHIC | 136141
18 | GRAPHIC | acrs-20250630xex99d1g016.jpg | GRAPHIC | 96888
19 | GRAPHIC | acrs-20250630xex99d1g017.jpg | GRAPHIC | 88173
20 | GRAPHIC | acrs-20250630xex99d1g018.jpg | GRAPHIC | 142642
21 | GRAPHIC | acrs-20250630xex99d1g019.jpg | GRAPHIC | 112797
22 | GRAPHIC | acrs-20250630xex99d1g020.jpg | GRAPHIC | 105297
23 | GRAPHIC | acrs-20250630xex99d1g021.jpg | GRAPHIC | 58806
24 | GRAPHIC | acrs-20250630xex99d1g022.jpg | GRAPHIC | 102751
25 | GRAPHIC | acrs-20250630xex99d1g023.jpg | GRAPHIC | 130913
26 | GRAPHIC | acrs-20250630xex99d1g024.jpg | GRAPHIC | 146224
27 | GRAPHIC | acrs-20250630xex99d1g025.jpg | GRAPHIC | 116678
28 | GRAPHIC | acrs-20250630xex99d1g026.jpg | GRAPHIC | 111943
29 | GRAPHIC | acrs-20250630xex99d1g027.jpg | GRAPHIC | 105027
30 | GRAPHIC | acrs-20250630xex99d1g028.jpg | GRAPHIC | 73503
31 | GRAPHIC | acrs-20250630xex99d1g029.jpg | GRAPHIC | 152697
32 | GRAPHIC | acrs-20250630xex99d1g030.jpg | GRAPHIC | 148868
33 | GRAPHIC | acrs-20250630xex99d1g031.jpg | GRAPHIC | 134585
| Complete submission text file | 0001558370-25-008984.txt |  | 5781175

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
34 | EX-101.SCH | acrs-20250630.xsd | EX-101.SCH | 3464
35 | EX-101.LAB | acrs-20250630_lab.xml | EX-101.LAB | 15918
36 | EX-101.PRE | acrs-20250630_pre.xml | EX-101.PRE | 10225
46 | EXTRACTED XBRL INSTANCE DOCUMENT | acrs-20250630x8k_htm.xml | XML | 4840

Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 251088719
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)